Denovo Sciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$200K
- Investors
-
6
Denovo Sciences General Information
Description
Developer of an AI-powered platform designed to optimize and advance the development of new therapeutics. The company utilizes computational simulations for directed search into chemical space, drug designing, generating polypharmacological compounds, and designing novel molecules, enabling medical professionals to increase their efficiency in the drug design process and efficiently explore chemical space for target-specific molecules.
Contact Information
Website
www.denovosciences.aiCorporate Office
- 138/2 Verin Antarain
- Yerevan, 0033
- Armenia
Corporate Office
- 138/2 Verin Antarain
- Yerevan, 0033
- Armenia
Denovo Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 27-Sep-2022 | $200K | Completed | Generating Revenue | ||
| 4. Seed Round | 27-Jun-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Sep-2021 | Completed | Generating Revenue | |||
| 2. Grant | 27-Jul-2021 | $20K | $125K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Dec-2020 | $125K | $125K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Denovo Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Denovo Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Denovo Sciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Berkeley SkyDeck | Accelerator/Incubator | |||
| Berkeley SkyDeck Fund | Venture Capital | Minority | ||
| Qatar Science & Technology Park | Venture Capital | Minority | ||
| Triple S Ventures | Venture Capital | Minority | ||
| Entrepreneurship World Cup | Other |
Denovo Sciences FAQs
-
When was Denovo Sciences founded?
Denovo Sciences was founded in 2019.
-
Where is Denovo Sciences headquartered?
Denovo Sciences is headquartered in Yerevan, Armenia.
-
What is the size of Denovo Sciences?
Denovo Sciences has 18 total employees.
-
What industry is Denovo Sciences in?
Denovo Sciences’s primary industry is Drug Discovery.
-
Is Denovo Sciences a private or public company?
Denovo Sciences is a Private company.
-
What is Denovo Sciences’s current revenue?
The current revenue for Denovo Sciences is .
-
How much funding has Denovo Sciences raised over time?
Denovo Sciences has raised $325K.
-
Who are Denovo Sciences’s investors?
Berkeley SkyDeck, Berkeley SkyDeck Fund, Qatar Science & Technology Park, Triple S Ventures, and Entrepreneurship World Cup are 5 of 6 investors who have invested in Denovo Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
